Top Tweets for #SFCancerSummit
Thanks to @ldtimmerman and @BiocominSF for an excellent #SFCancerSummit yesterday. The advances being made in the fight against #cancer — and the passion and commitment behind them — were truly inspiring to hear about. Veracyte is honored to be a part of it. @climbtofight
A whirlwind week at #SFCancerSummit and #BOSCancerSummit. So much cool cancer biology, and interesting puzzles for industry to solve. Thanks to all the speakers and to everyone who attended these special biopharma community idea and networking events. #grateful @climbtofight
Hal Barron recalls studying under Ira Mellman at Yale in 1986. 'Only thing I remember is him saying Hal, the immune system is really important.' Didn't get it then. He said the same thing when we reunited at Genentech. Still true #SFCancerSummit
Hal Barron: in 4 years at Calico, a Google co, I learned a bit about large data. We don't have it yet in biology. Tech laughs at us. For now, AI in drug discovery over hyped. #SFCancerSummit
Hal Barron: model org of the future will be a human. We are getting so much sequence data from millions of patients. The functional genomics screens with CRISPR knockouts at high throughput are going to give us insight into combo therapy. #SFCancerSummit
Larry Corey, past president of @fredhutch: we have way higher participation rates in clinical trials for HIV than cancer. Something needs to change with cancer research admin to improve participation. #SFCancerSummit
Hal Barron: we can do gene-by-gene interaction networks with thousands of genes, in mammalian cells. Five years ago, people thought no way it would be possible this soon. Paving the way for more rational drug discovery #SFCancerSummit
Hal Barron: We're getting massive dimensionality in biology data. No human will be able to analyze it. #SFCancerSummit
In panel discussion moderated by @lesleystolz, @BonnieAndDx and @KevinConroyCEO both point out that for molecular diagnostic tests to succeed, “you can’t cut corners” when it comes to building the clinical evidence to support them. #SFCancerSummit
Kevin Conroy said @ExactSciences is switching to Epic from internal software for 2m Cologuard patients & 120k prescribing physicians. Usually not sold to cos. Only health systems. @KevinConroyCEO says it should help in era of real world evid, patients owning data #SFCancerSummit
Talking T-cells, proteomics, single-cell genomics, bi-specifics, and the spectacular work happening now to better understand and create therapies for cancer at #SFCancerSummit with @ldtimmerman @climbtofight @JLABS
Thanks to @BiocominSF and J&J Innovation and @fredhutch for all the behind the scenes work at #SFCancerSummit . Great teamwork
So grateful to host #SFCancerSummit! A packed room full of life science professionals eager to learn how to further develop cancer treatments.
So grateful to host #SFCancerSummit! A packed room full of life science professionals eager to learn how to further develop cancer treatments.
Nina Kjellson, with mic, driving an excellent panel on 'Beyond the Science'. The nitty gritty manufacturing, software logistics, reimbursement challenges for cell therapy. @NinaKjellson on the Kilimanjaro @climbtofight team. She's a force. #SFCancerSummit
Ashley Koegel of UCSF, a pediatric oncologist sitting next to Nina, says they just dosed their youngest CAR-T patient. On outpatient basis. Age 2. Doing well at home now, she says. Wow. #SFCancerSummit
Nina Kjellson, with mic, driving an excellent panel on 'Beyond the Science'. The nitty gritty manufacturing, software logistics, reimbursement challenges for cell therapy. @NinaKjellson on the Kilimanjaro @climbtofight team. She's a force. #SFCancerSummit
Julia Owens asks about spiraling costs. Asking about reduced costs of goods. Bassil Dahiyat says that's not the issue 'profit margins on antibodies are staggering. Price is a choice.' Rocking the boat in a room of entrepreneurs and investors. #SFCancerSummit
Bassil Dahiyat of Xencor: inducing cytokine storms still the No. 1 challenge facing bispecifics. #SFCancerSummit
David Chang of Allogene Therapeutics, fmr Kite, mentions he's in recruiter mode for an R&D head. This is not a bad pond to fish for candidates. #SFCancerSummit
Where do T cell therapies make most sense, and where might bispecifics? @juliacowens moderating with Juno co founder Stan Riddell, Xencor CEO Bassil Dahiyat, and Allogene Therapeutics CEO David Chang. #SFCancerSummit
Last Seen Hashtags on Sotwe
備後ひばり
Seen from Japan
anxiouspandaa ()(*)+filter:media since:2026-10-17
Seen from Turkey
anxiouspandaa
Seen from United States
nudes
Seen from Spain
findomsg
Seen from Singapore
sixpack
Seen from Thailand
gilf(*)
Seen from Vietnam
cathyheaven
Seen from Pakistan
girlwedgie
Seen from United Kingdom
minichatt()**********
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers